{"product_id":"clot-management-devices-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Clot Management Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eClot Management Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global clot management devices market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.58% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eClot management devices refer to the medical equipment that are used for the treatment of ailments such as pulmonary embolism (PE), arterial blood clots and deep vein thrombosis (DVT). Some of the commonly used clot management devices include catheter-directed thrombolysis (CDT) devices, embolectomy balloon catheters, percutaneous thrombectomy devices, neurovascular embolectomy devices and inferior vena cava filters (IVCFs). These devices aid in inhibiting the development of blood clots in the heart, brain, lungs and legs of the patient, thereby preventing the instances of potential ischemic strokes, severe leg pain and heart attacks.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Clot Management Devices Market Trends:\u003cbr\u003e\nThe increasing prevalence of cardiovascular diseases (CVDs), along with the rising geriatric population across the globe, is one of the key factors driving the growth of the market. Owing to the sedentary lifestyles and unhealthy dietary habits, a greater number of individuals are suffering from heart ailments, DVT and PE, thereby enhancing the demand for clot management devices. Furthermore, the growing preference for minimally invasive (MI) procedures by both patients and healthcare providers is also boosting the market growth. For instance, mechanical thrombectomy is an MI procedure in which the surgeon uses specialized equipment to remove the clot from the patient’s artery through a small incision. Apart from this, the increasing instances of hip, knee and spinal injuries that require catheter-directed thrombolysis, have also created a positive impact on the market growth. Other factors, including various technological advancements, such as the development of next-generation thrombectomy devices, the continual launch of cost-effective devices, along with extensive research and development (R\u0026amp;D) activities in the field of medical sciences, are projected to drive the market further.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global clot management devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product Type:\u003c\/p\u003e\n\n\u003cp\u003eNeurovascular Embolectomy Devices\u003cbr\u003e\nEmbolectomy Balloon Catheters\u003cbr\u003e\nPercutaneous Thrombectomy Devices\u003cbr\u003e\nMechanical Thrombectomy\u003cbr\u003e\nAspiration Thrombectomy\u003cbr\u003e\nPercutaneous Mechanical Thrombectomy (PMT)\u003cbr\u003e\nCatheter-Directed Thrombolysis Devices\u003cbr\u003e\nInferior Vena Cava Filters\u003cbr\u003e\nPermanent\u003cbr\u003e\nRetrievable\u003cbr\u003e\n \u003cbr\u003e\nBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nDiagnostic Centers and Specialty Clinics\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe report has also analysed the competitive landscape of the market with some of the key players being AngioDynamics Inc., Argon Medical Devices Inc., Boston Scientific Corporation, DePuy Synthes Inc., Edwards Lifesciences Corporation, iVascular S.L.U., Lemaitre Vascular Inc., Medtronic Inc., Straub Medical AG, Stryker Corporation, Teleflex Incorporated, Vascular Solutions, etc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global clot management devices market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global clot management devices market?\u003cbr\u003e\nWhat is the breakup of the market based on the product type?\u003cbr\u003e\nWhat is the breakup of the market based on the end-user?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global clot management devices market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 138 Pages \/ MCW16254361","offer_id":47649309524274,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/clot-management-devices-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}